Treatment of severe IgA nephropathy: Mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone

International Journal of Clinical Pharmacology and Therapeutics

Volumn 52, Issue 2, 2014, Pages 95-102

  Liu, Xiaowei ^a   Dewei, Du ^b   Sun, Shiren ^a   Xu, Guoshuang ^a   Liu, Hongbao ^a   He, Lijie ^a   Zhang, Peng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclophosphamide; Mycophenolate mofetil; Severe IgA nephropathy

Indexed keywords

ADULT; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPIDS; MALE; MYCOPHENOLIC ACID; PREDNISONE; SERUM ALBUMIN;

EID: 84894263177     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201887     Document Type: Article

References (28)

1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002; 347: 738-748. CrossRef PubMed (Pubitemid 35203906)
2. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001; 60: 1948-1954. CrossRef PubMed (Pubitemid 33000001)
3. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol. 2005; 16: 2088-2097. CrossRef PubMed (Pubitemid 41716440)
4. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS. Histological grading of IgA nephropathy predicting renal outcome: revisiting H.S. Lee's glomerular grading system. Nephrol Dial Transplant. 2005; 20: 342-348. CrossRef PubMed (Pubitemid 40276890)
5. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol. 2002; 13: 142-148. PubMed (Pubitemid 34042021)
6. Mera J, Uchida S, Nagase M. Clinicopathologic study on prognostic markers in IgA nephropathy. Nephron. 2000; 84: 148-157. CrossRef PubMed (Pubitemid 30081564)
7. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton). 2004; 9: 177-185. CrossRef PubMed (Pubitemid 39318639)
8. Roccatello D, Ferro M, Cesano G, Rossi D, Berutti S, Salomone M, Piccoli G, Sena LM. Steroid and cyclophosphamide in IgA nephropathy. Nephrol Dial Transplant. 2000; 15: 833-835. CrossRef PubMed (Pubitemid 30312002)
9. Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy. Clin Nephrol. 2000; 53: 1-9. PubMed (Pubitemid 30046897)
10. Tumlin JA, Lohavichan V, Hennigar R. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrol Dial Transplant. 2003; 18: 1321-1329. CrossRef PubMed (Pubitemid 36826953)
11. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003; 362: 629-639. CrossRef PubMed (Pubitemid 37013306)
12. Chen KJ, Cheng CH, Wu MJ, Chen CH, Shu KH. Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes. J Chin Med Assoc. 2003; 66: 263-270. PubMed
13. Tang S, Leung J, Tang A, Ho Y, Chan L, Chan D, Lai K. A prospective randomized case-controlled study on the efficacy of mycophenolate mofetil for IgA nephropathy patients with persistent proteinuria despite angiotensin blockade. J Am Soc Nephrol. 2003; 14: 725A.
14. Maes BD, Oyen R, Claes K, Evenepoel P, Kuypers D, Vanwalleghem J, Van Damme B, Vanrenterghem YF. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int. 2004; 65: 1842-1849. CrossRef PubMed (Pubitemid 38591034)
15. Chen X, Chen P, Cai G. A randomized control trial of mycophenolate mofetil treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi (Taipei). 2001; 82: 796-801.
16. Huang Y, Liu Z, Huang H, Liu H, Li L. Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol. 2005; 5: 1029-1039. CrossRef PubMed
17. Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah WAN, Tan CC, Morad Z. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton). 2005; 10: 504-510. CrossRef PubMed (Pubitemid 41727277)
18. Bullo B, Zdrojewski Z, Rutkowski B. Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN). Kidney Int. 2003; 64: 1139. CrossRef PubMed (Pubitemid 37013856)
19. Roccatello D, Rossi D, Marletto F, Naretto C, Sciascia S, Baldovino S, Piras D, Giachino O. Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. J Nephrol. 2012; 25: 198-203. CrossRef PubMed
20. Tang SC, Tang AW, Wong SS, Leung JC, Ho YW, Lai KN. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int. 2010; 77: 543-549. CrossRef PubMed
21. Liu XW, Li DM, Xu GS, Sun SR. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome. Int J Clin Pharmacol Ther. 2010; 48: 509-513. PubMed
22. Frisch G, Lin J, Rosenstock J, Markowitz G, D'Agati V, Radhakrishnan J, Preddie D, Crew J, Valeri A, Appel G. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant. 2005; 20: 2139-2145. CrossRef PubMed (Pubitemid 41510089)
23. Tang S, Leung JC, Chan LY, Lui YH, Tang CS, Kan CH, Ho YW, Lai KN. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int. 2005; 68: 802-812. CrossRef PubMed (Pubitemid 43323137)
24. Mitsuiki K, Harada A, Okura T, Higaki J. Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide. Clin Exp Nephrol. 2007; 11: 297-303. CrossRef PubMed (Pubitemid 350277614)
25. Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH. Effects of triple therapy in IgA nephritis: a followup study 5 years later. Clin Nephrol. 1991; 36: 60-66. PubMed
26. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron. 1996; 72: 237-242. CrossRef PubMed
27. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999; 353: 883-887. CrossRef PubMed (Pubitemid 29126876)
28. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A et al; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009; 76: 546-556. CrossRef PubMed